-
Abstract Number: OC 07.2
Macrophage Galactose Lectin (MGL) is a clearance receptor determining Factor VIII half-life in haemophilia A patients
-
Abstract Number: OC 34.3
Major gastrointestinal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: a score to identify high risk patients
-
Abstract Number: PB0001
Management of acquired haemophilia A in a Portuguese Center: 16 years and 16 cases
-
Abstract Number: PB0847
Management of adult idiopathic thrombocytopenic purpura (ITP) patients with antinuclear antibody (ANA)
-
Abstract Number: PB1411
Management of Antithrombin Deficiency in Pregnancy – 2 cases report
-
Abstract Number: PB1402
Management of Inherited Antithrombin Deficiency in Pregnancy: The Western Australian Experience
-
Abstract Number: PB0496
Management of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation in Spain. RE-BELD study
-
Abstract Number: OC 23.1
Management of Patients with Unprovoked Venous Thromboembolism and a Low Risk of Recurrence with the Vienna Prediction Model: A Prospective Cohort Study
-
Abstract Number: PB1319
Management of superficial venous thrombosis based on individual risk profiles: protocol for the development and validation of three prognostic prediction models in large primary care cohorts
-
Abstract Number: OC 04.1
Management of thrombotic thrombocytopenic purpura (TTP) without plasma exchange: an update on the Austrian experience
-
Abstract Number: PB1266
Maphosphamide, a cyclophosphamide analog, increases proinflammatory and permeability responses on endothelial cells in vitro
-
Abstract Number: OC 39.3
Mapping hemorrhagic stroke in the fetal and neonatal period as a consequence of thrombocytopenia.
-
Abstract Number: VPB1419
Markers of endothelial dysfunction as predictors of recurrent severe preeclampsia
-
Abstract Number: PB1035
Mathematical modeling suggests the importance of TFPI-mediated inhibition of platelet-surface bound proteins during coagulation under flow
-
Abstract Number: OC 07.5
Mathematical modeling to identify clotting factor combinations that enhance thrombin generation in hemophilia
-
Abstract Number: VPB0903
Matrix metalloproteinase-13: a novel player of platelet activation and in vivo thrombus formation
-
Abstract Number: PB0073
Matrix metalloproteinases are associated with poor prognosis in hospitalized patients with COVID-19
-
Abstract Number: PB1101
Measurement of fibrinogen using two concentrations of Thrombin with patients receiving Argatroban or normal plasma spiked with Argatroban: a review of UK NEQAS (Blood Coagulation) exercises 2021.
-
Abstract Number: PB0993
Measurement of procoagulant platelets in platelet-rich plasma by flow cytometer for the diagnosis of heparin-induced thrombocytopenia
-
Abstract Number: PB0546
Measurement of β-antithrombin activity in healthy individuals and in patients with different types of antithrombin deficiency
-
Abstract Number: PB0970
Measuring Factor VII Activating Protease (FSAP) in venous thrombosis using a newly developed FSAP generation assay
-
Abstract Number: PB1273
Mechanical Injury of a tissue-engineered human arterial construct replicates the thrombotic and pharmacological properties of the native artery.
-
Abstract Number: VPB1301
Mechanism of hepatocyte growth factor-induced decreased expression of protein C inhibitor in HepG2 cells
-
Abstract Number: PB0931
Mechanisms of cancer associated thrombosis in gynaecological cancer patients-tumour or treatment effect?
-
Abstract Number: VPB0899
Mechanisms of HLA-KO iPSC-platelets immune escape from NK cells
-
Abstract Number: PB0875
Mechanosensitive Ion Channels Piezo1 in Red Blood Cells are Involved in Platelet-Driven Blood Clot Contraction
-
Abstract Number: PB0448
Median serum trough concentration of apixaban in pulmonary embolism patients after one month of therapy
-
Abstract Number: PB0659
Medically Recorded Bleeds and Healthcare Resource Use in the United States Among Adult Males With Hemophilia A
-
Abstract Number: OC 59.3
Megakaryocyte Engraftment and altered Platelet Function in a Murine Model of Hematopoietic Stem Cell Transplantation
-
Abstract Number: PB0357
Megakaryocyte-Driven Blood Clot Contraction and its Structural Mechanisms
-
Abstract Number: OC 15.4
Menstrual bleeding in adolescents taking dabigatran for acute VTE treatment and secondary prevention
-
Abstract Number: VPB0790
Meta-analysis of the frequency of platelet hyperreactivity after antiplatelet treatment in patients with diabetes and hypertension, undergoing percutaneous coronary intervention, 2005–2021
-
Abstract Number: OC 19.2
Metabolic reprogramming is essential for myeloid cell-dependent haemostatic activity
-
Abstract Number: PB0305
Method and laboratory specific clinical cut-offs support appropriate interpretation of ADAMTS13 activity assays
-
Abstract Number: PB0308
Method Discrepant ADAMTS-13 activity results in first presentation query TTP subjects
-
Abstract Number: PB0982
MGUS-IgA with anti-thrombin activity in a patient with a severe acquired haemorrhagic syndrome.
-
Abstract Number: OC 37.3
Mice possess a more limited natural anti-FVIII antibody repertoire than humans that is generated primarily by marginal zone B cells
-
Abstract Number: PB1106
Microfluidic Thromboelastography (Micro-TEG)
-
Abstract Number: PB0909
Microparticles and D-Dimers improve prediction of chemotherapy- associated thrombosis in cancer patients
-
Abstract Number: PB0580
Microvesicles from Stored Platelets Promote High Molecular Weight Kininogen Cleavage Leading to Bradykinin Generation.
-
Abstract Number: PB1151
Mild Bleeding Phenotypes in Severe Hemophilia A with Transfusion Dependent Alpha-thalassemia
-
Abstract Number: PB0223
Mim8 does not affect FVIII function in hemophilia A
-
Abstract Number: OC 50.5
Mim8 is associated with improved thrombin generation vs. emicizumab in patients with haemophilia A, with and without inhibitors
-
Abstract Number: VPB1006
Mini-invasive surgical treatment of haemorrhoiadal bleeding in patients with cardiovascular disease under antithrombotic therapy
-
Abstract Number: PB0655
Minor surgical procedures and the outcome of immunotolerance induction: an analysis of the BrazIT Study
-
Abstract Number: OC 18.3
MiR-146a seeds a pro-inflammatory state in acute myocardial infarction of young patients promoting recurrence
-
Abstract Number: OC 49.5
Mitochondrial ATP generation in stimulated platelets is essential for granule secretion but dispensable for aggregation and procoagulant activity
-
Abstract Number: OC 66.5
Mitochondrial dysfunction in platelets from patients with JAK2 V617F essential thrombocythemia and polycythemia vera underlie thrombo-hemorrhagic complications
-
Abstract Number: PB0834
Mixed Phenotype 1/2E Von Willebrand Disease in Two Slovak Patients: Case Report
-
Abstract Number: VPB0349
ML355 modulates platelet activation and prevents ABT-737 induced apoptosis in platelets
-
Abstract Number: OC 52.1
Mode of delivery and intracranial hemorrhage in newborns with hemophilia: A Systematic Review and Meta-analysis
-
Abstract Number: PB0511
Model of P2RY12 -T-744C, (GPIbα) – C482T, NOS3 – T-786C, MTHFR – C667T Gene Interactions in Patients with High Cardiovascular Risk
-
Abstract Number: OC 64.4
Modeling gray platelet syndrome: longitudinal mouse studies and in vitro human iPSC-derived megakaryocytes to investigate clinical and cellular features
-
Abstract Number: PB1282
Models for identification of endothelial glycocalyx degradation mechanisms during Puumala virus infection
-
Abstract Number: PB1158
MOdern Treatment of Inhibitor-PositiVe PATiEnts with Haemophilia A – MOTIVATE (www.motivate-study.com)
-
Abstract Number: OC 24.5
Modest Performance of Available Risk Prediction Models when Used to Predict Hemorrhage in Patients with Chronic Liver Disease
-
Abstract Number: PB0562
Modifications in the Thrombin Active Site S4 Subpocket Induce Resistance to Direct Thrombin Inhibitors
-
Abstract Number: PB1258
Modulation of monocytes inflammatory and hemostatic phenotype after transcatheter aortic valve replacement and consequences on post-procedural complications
-
Abstract Number: VPB0645
Modulation of plasmin inhibitor activities, using Affimer technology, improves the hypofibrinolytic environment in high vascular risk individuals
-
Abstract Number: PB0200
Molecular algorithm for genetic diagnosis of women with hemophilia A in Argentina
-
Abstract Number: PB1157
Molecular analysis of inherited bleeding disorders in North Indian cohort
-
Abstract Number: OC 76.3
Molecular Basis for the Conformational Selectivity of Thrombomodulin for TAFI or Protein C
-
Abstract Number: PB0202
Molecular Characterization Of The F9 Missense Variants
-
Abstract Number: PB0362
Molecular insights into the cause and treatment of congenital thrombocytopenia in mice lacking the co-inhibitory receptor G6b-B
-
Abstract Number: VPB0408
Molecular mechanisms of apoptosis in platelets and megakaryocytes in pediatric immune thrombocytopenia
-
Abstract Number: PB0554
Molecular, laboratory and clinical characteristics of inherited antithrombin deficiency: a large, single centre cohort study from the United Kingdom.
-
Abstract Number: PB0175
Monitoring emicizumab with global coagulation assays
-
Abstract Number: PB1022
Monitoring hemostasis with Rotational Thromboelastometry (ROTEM) in patients undergoing aortic valve replacement surgery.
-
Abstract Number: PB0242
Monitoring of hemostasis and heparinization of neonates undergoing cardiac surgery (CS) using viscoelastic testing (VT) and standard laboratory test (SLT).
-
Abstract Number: PB1202
Monitoring the persistence of vaccine-induced immune thrombotic thrombocytopenia (VITT) antibodies and their pathogenicity
-
Abstract Number: VPB1341
Mortality associated with venous thrombosis in Brazil: evidence of inequalities between low/middle- and high-income countries
-
Abstract Number: PB0145
MRP-4 («Multidrug Resistance Protein-4) PROTEIN EXPRESSION IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) UNDER CHRONIC ASPIRIN TREATMENT
-
Abstract Number: PB0301
Multi-centre performance evaluation of ADAMTS13 activity quantification using three different measurement technologies
-
Abstract Number: VPB1379
Multi-dimensional instrument assessment of adherence to warfarin therapy: methodological study
-
Abstract Number: PB0799
Multi-scale modeling of SIPA showing VWF agglomeration and capture of platelets with high shear
-
Abstract Number: PB1061
Multicentre Performance Evaluation and Reference Range for an Immunoassay for the Quantitative Determination of Factor XIII Antigen on the cobas t 711 Analyser
-
Abstract Number: PB1060
Multicentre Performance Evaluation and Reference Range for the Quantitative Determination of Factor IX Activity on the cobas t 711 Analyser
-
Abstract Number: PB1271
Multiparameter analysis of the time-dependent roles of Platelet and Coagulation Pathways in Collagen- and Tissue Factor-Induced Thrombus Formation
-
Abstract Number: PB0510
Multiple Myeloma (MM) is Associated with an Increased Risk of Arterial Thromboembolic Events (ATE)
-
Abstract Number: PB1125
Musculoskeletal health and health-related quality of life in patients switching to emicizumab prophylaxis
-
Abstract Number: PB0032
Myeloperoxidase-DNA Serum Titers and Delayed Cerebral Ischemia in Patients With Aneurysmal Subarachnoid Hemorrhage
-
Abstract Number: PO0045
Mystery of reversible neonatal toes gangrene : Case Report
ISTH 2022 Congress
July 9-13, 2022. London, England, UK.